Down-regulation of hepatic high-density lipoprotein receptor, SR-B1, in nephrotic syndrome

Kidney International

Volumn 56, Issue 2, 1999, Pages 621-626

  Liang, Kaihui ^a   Vaziri, Nosratola D ^a,b  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

Apolipoprotein A I; Cholesterol; Hyperlipidemia; Lipids; Proteinuria; Scavenger receptor

Indexed keywords

APOLIPOPROTEIN A1; CHOLESTEROL; LIPID; LOW DENSITY LIPOPROTEIN RECEPTOR; MESSENGER RNA; SCAVENGER RECEPTOR; TRIACYLGLYCEROL;

ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CHOLESTEROL TRANSPORT; CONTROLLED STUDY; HYPERLIPIDEMIA; IMMUNOBLOTTING; LIPID METABOLISM; LIVER; MALE; NEPHROTIC SYNDROME; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEINURIA; RAT; RECEPTOR DOWN REGULATION;

EID: 0032810637     PISSN: 00852538     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1523-1755.1999.00585.x     Document Type: Article

References (22)

1. 1. KAYSEN GA, HOYE E, JONES H JR: Apolipoprotein A-I levels are increased in part as a consequence of reduced catabolism in nephrotic rats. Am J Physiol 268:F532-F540, 1995
2. 2. SUN X, JONES H JR, JOLES JA, VAN TOL A, KAYSEN GA: Apolipoprotein gene expression in analbuminemic rats and in rats with Heymann nephritis. Am J Physiol 262:F755-F761, 1992
3. 3. TARUGI P, CALANDRA S, CHAN L: Changes in apolipoprotein A-I mRNA level in the liver of rats with experimental nephrotic syndrome. Biochim Biophys Acta 868:51-61, 1986
4. 4. MARSHAL JF, APOSTOLOPOULOS JJ, BRACK CM, HOWLETT CJ: Regulation of apolipoprotein gene expression and plasma high density lipoprotein composition in experimental nephrosis. Biochim Biophys Acta 1042:271-279, 1990
5. 5. VAN GOOR H, VAN DER HORST ML, ATMOSOERODJO J, JOLES JA, VAN TOL A, GROND J: Renal apolipoproteins in nephrotic rats. Am J Pathol 142:1804-1812, 1993
6. 6. ACTON SL, ROGITT A, LANDSCHULZ KT, XU S, HOBBS HH, KRIEGER M: Identification of scavenger receptor SR-B1 as a high density lipoprotein receptor. Science 271:518-520, 1996
7. 7. ACTON SL, SCHERER PE, LODISH HF, KRIEGER M: Expression cloning of SR-B1, a CD36-related class B scavenger receptor. J Biol Chem 269:21003-21009, 1994
8. 8. VAZIRI ND, LIANG K: Down-regulation of VLDL receptor expression in chronic experimental renal failure. Kidney Int 51:913-919, 1997
9. 9. VAZIRI ND, LIANG K: Down-regulation of hepatic LDL receptor expression in experimental nephrosis. Kidney Int 50:887-893, 1996
10. 10. SPARKS CE, TENNENBERG, SD, MARSH JB: Catabolism of the apolipoproteins of HDL in control and nephrotic rats. Biochim Biophys Acta 665:8-12, 1981
11. 11. SAKU K, MENDOZA SG, LAVER M, HYND BA, GARTSIDE PS, KASHYAP ML: High-density lipoprotein apolipoprotein A I and A II turnover in moderate and severe proteinuria. Nephron 50:112-115, 1998
12. 12. DULLAART RP, GANSEVOORT RT, DIKKESCHEI BD, DE ZEEUW D, DE JONG PE, VAN TOL A: Role of elevated lecithin: Cholesterol acyltransferase and cholesteryl ester transfer protein activities in abnormal lipoproteins from proteinuric patients. Kidney Int 44: 91-97, 1993
13. 13. OSCHRY Y, EISENBERG S: Rat plasma lipoproteins: Reevaluation of a lipoprotein system in an animal devoid of cholesteryl ester transfer activity. J Lipid Res 23:1099-1106, 1982
14. 14. TALL AR: Plasma high density lipoproteins: Metabolism and relationship to atherogenesis. J Clin Invest 86:379-384, 1990
15. 15. IKEWAKI K, RADER DJ, SAKAMOTO T, NISHIWAKI M, WAKIMOTO N, SCHAEFER JR, ISHIKAWA T, FAIRWELL T, ZECH LA, NAKAMURA H, NAGANO M, BREWER HB JR: Delayed catabolism of high-density lipoprotein apolipoproteins A-I and A-II in human cholesterol ester transfer protein deficiency. J Clin Invest 92:1650-1658, 1993
16. 16. GLASS CK, PITTMAN RC, KELLER GA, STEINBERG D: Tissue sites of degradation of apoprotein AI in the rat. J Biol Chem 258:7161-7167, 1983
17. 2 cells. Arterioscler Thromb Vasc Biol 17:2020-2028, 1997
18. 18. LIANG K, VAZIRI ND: Acquired VLDL receptor deficiency in experimental nephrosis. Kidney Int 51:1761-1765, 1997
19. 19. LIANG K, VAZIRI ND: Gene expression of lipoprotein lipase in experimental nephrosis. J Lab Clin Med 130:387-394, 1997
20. 20. LIANG K, VAZIRI ND: Down regulation of hepatic lipase expression in experimental nephrotic syndrome. Kidney Int 51:1933-1937, 1997
21. 21. VAZIRI ND, LIANG K: Hepatic HMG-CoA reductase gene expression during the course of puromycin-induced nephrosis. Kidney Int 48:1979-1985, 1995
22. 22. LIANG K, OVEISI F, VAZIRI ND: Gene expression of hepatic cholesterol 7α-hydroxylase in the course of puromycin-induced nephrosis. Kidney Int 49:855-860, 1996